Revlimid 10 MG capsule 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FXR1Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,176
Award facts
- Contract value 100% obligated
- $19,176.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19.2K delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 7, 2026, for the supply of Revlimid 10 mg capsules in quantities of 28 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 29, 2026. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and runs through December 2026, establishing a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with an extensive portfolio spanning multiple therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The company's federal contracting history demonstrates consistent capability in fulfilling diverse pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitive procurement processes. The Revlimid order represents one of numerous task orders executed under the company's primary IDC vehicle, reflecting AmerisourceBergen's ongoing role in supporting military treatment facilities and veteran healthcare programs with essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26FXR1Z?
SPE2DR26FXR1Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FXR1Z worth?
The government has obligated $19,176 on SPE2DR26FXR1Z.
Is contract SPE2DR26FXR1Z an order under another contract?
Yes. SPE2DR26FXR1Z is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXR1Z competed?
The extent of competition for SPE2DR26FXR1Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award